Rider, L.G., Werth, V.P., Huber, A.M., et al. (2011) Measures of Adult and Juvenile Dermatomyositis, Polymyositis, and Inclusion Body Myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care & Research, 63, S118-S157.
https://doi.org/10.1002/acr.20532

has been cited by the following article:

• TITLE: Transcranial Direct Current Stimulation Is Safe and Relieves Post-Herpetic Neuralgia in Patient with Dermatomyositis: A Case Report

  AUTHORS: Rafael Giovani Misse, Alexandre Moura dos Santos, Abrahão Fontes Baptista, Samuel Katsuyuki Shinjo

  KEYWORDS: Cerebral Neuromodulation, Dermatomyositis, Neuralgia, Pain, Treatment

  JOURNAL NAME: Open Journal of Rheumatology and Autoimmune Diseases, Vol.12 No.4, November 4, 2022

  ABSTRACT: To the best of our knowledge, this is the first report in the literature showing the efficacy of transcranial direct current stimulation (tDCS) in treating refractory post-herpetic neuralgia in a patient with dermatomyositis. In addition, our results showed that tDCS sessions are safe and do not lead to disease relapse. Therefore, despite the limitations of being a case report, this study provides encouraging results that need to be widely explored in studies with a representative number of patients and with an appropriate design for patients with this systemic rheumatic autoimmune disease.